Clinical Trial Update: Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression [NA]

View source ↗

Summary

A clinical trial update on using DNA testing and gene expression profiling to help transition kidney transplant recipients to belatacept-only immunosuppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Kidney Transplant Immunosuppression | NA | Status: ENROLLING_BY_INVITATION